{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T15:42:55Z","timestamp":1786203775875,"version":"build-2736575974"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00520-026-11000-6","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:45:16Z","timestamp":1784079916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Patient-reported symptom assessments and early chemotherapy discontinuation in routine gastrointestinal cancer care"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3512-1115","authenticated-orcid":false,"given":"Chengbo","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumenghui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra C.","family":"Olisakwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia C.","family":"Dykes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nneka N.","family":"Ufere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth S.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria O.","family":"Edelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Pusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly M.","family":"Kenzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey S.","family":"Lau-Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason B.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"issue":"6","key":"11000_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34(6):557\u2013565. https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"J Clin Oncol"},{"issue":"24","key":"11000_CR2","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1001\/jama.2022.9265","volume":"327","author":"E Basch","year":"2022","unstructured":"Basch E, Schrag D, Henson S et al (2022) Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. JAMA 327(24):2413\u20132422. https:\/\/doi.org\/10.1001\/jama.2022.9265","journal-title":"JAMA"},{"issue":"6","key":"11000_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/s41591-022-01788-1","volume":"28","author":"O Mir","year":"2022","unstructured":"Mir O, Ferrua M, Fourcade A et al (2022) Digital remote monitoring plus usual care versus usual care in patients treated with oral anticancer agents: the randomized phase 3 CAPRI trial. Nat Med 28(6):1224\u20131231. https:\/\/doi.org\/10.1038\/s41591-022-01788-1","journal-title":"Nat Med"},{"key":"11000_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184615","author":"L Lizan","year":"2021","unstructured":"Lizan L, Perez-Carbonell L, Comellas M (2021) Additional value of patient-reported symptom monitoring in cancer care: a systematic review of the literature. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13184615","journal-title":"Cancers (Basel)"},{"issue":"1","key":"11000_CR5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41746-025-01812-x","volume":"8","author":"Y Xia","year":"2025","unstructured":"Xia Y, Guan X, Zhu W, Wang Y, Shi Z, He P (2025) Effectiveness of symptom monitoring on electronic patient-reported outcomes (ePROs) among patients with lung cancer: a systematic review and meta-analysis. NPJ Digit Med 8(1):399. https:\/\/doi.org\/10.1038\/s41746-025-01812-x","journal-title":"NPJ Digit Med"},{"issue":"12","key":"11000_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2024-097127","volume":"14","author":"C Zeng","year":"2024","unstructured":"Zeng C, Martin NE, Pusic AL, Edelen MO, Liu JB (2024) Enhancing representativeness of patient-reported outcomes in routine radiation oncology care: a quality improvement protocol to address non-response. BMJ Open 14(12):e097127. https:\/\/doi.org\/10.1136\/bmjopen-2024-097127","journal-title":"BMJ Open"},{"issue":"11","key":"11000_CR7","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1007\/s11136-020-02564-9","volume":"30","author":"AM Stover","year":"2021","unstructured":"Stover AM, Haverman L, van Oers HA, Greenhalgh J, Potter CM, Group IPPiCPISW (2021) Using an implementation science approach to implement and evaluate patient-reported outcome measures (PROM) initiatives in routine care settings. Qual Life Res 30(11):3015\u20133033. https:\/\/doi.org\/10.1007\/s11136-020-02564-9","journal-title":"Qual Life Res"},{"key":"11000_CR8","doi-asserted-by":"publisher","DOI":"10.1200\/CCI.22.00187","volume":"7","author":"E Basch","year":"2023","unstructured":"Basch E, Rocque G, Mody G, Mullangi S, Patt D (Feb2023) Tenets for implementing electronic patient-reported outcomes for remote symptom monitoring during cancer treatment. JCO Clin Cancer Inform 7:e2200187. https:\/\/doi.org\/10.1200\/CCI.22.00187","journal-title":"JCO Clin Cancer Inform"},{"key":"11000_CR9","doi-asserted-by":"publisher","DOI":"10.1200\/OP-24-00627","author":"GN Mody","year":"2025","unstructured":"Mody GN, Bennett AV, Stover AM et al (2025) Implementation of symptom monitoring with electronic patient-reported outcomes: perspectives and recommendations from community oncology practices (Alliance AFT-39). JCO Oncol Pract. https:\/\/doi.org\/10.1200\/OP-24-00627","journal-title":"JCO Oncol Pract"},{"key":"11000_CR10","doi-asserted-by":"publisher","unstructured":"Liu JB, Kaplan RS, Bates DW, Edelen MO, Sisodia RC, Pusic AL (2024) Mass General Brigham\u2019s patient-reported outcomes measurement system: a decade of learnings. NEJM Catalyst\u00a05(7)https:\/\/doi.org\/10.1056\/cat.23.0397","DOI":"10.1056\/cat.23.0397"},{"issue":"6","key":"11000_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.29452","volume":"69","author":"PS Hinds","year":"2022","unstructured":"Hinds PS, Pinheiro LC, McFatrich M et al (2022) Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events. Pediatr Blood Cancer 69(6):e29452. https:\/\/doi.org\/10.1002\/pbc.29452","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"11000_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s13142-015-0345-9","volume":"6","author":"AW Smith","year":"2016","unstructured":"Smith AW, Mitchell SA, C KDA et al (Sep2016) News from the NIH: person-centered outcomes measurement: NIH-supported measurement systems to evaluate self-assessed health, functional performance, and symptomatic toxicity. Transl Behav Med 6(3):470\u20134. https:\/\/doi.org\/10.1007\/s13142-015-0345-9","journal-title":"Transl Behav Med"},{"key":"11000_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju129","author":"BB Reeve","year":"2014","unstructured":"Reeve BB, Mitchell SA, Dueck AC et al (2014) Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. J Natl Cancer Inst. https:\/\/doi.org\/10.1093\/jnci\/dju129","journal-title":"J Natl Cancer Inst"},{"issue":"3-4","key":"11000_CR14","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/jocn.14057","volume":"27","author":"C Ward Sullivan","year":"2018","unstructured":"Ward Sullivan C, Leutwyler H, Dunn LB, Miaskowski C (2018) A review of the literature on symptom clusters in studies that included oncology patients receiving primary or adjuvant chemotherapy. J Clin Nurs 27(3\u20134):516\u2013545. https:\/\/doi.org\/10.1111\/jocn.14057","journal-title":"J Clin Nurs"},{"issue":"1","key":"11000_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/bmjspcare-2021-003325","volume":"12","author":"CS Harris","year":"2022","unstructured":"Harris CS, Kober KM, Conley YP, Dhruva AA, Hammer MJ, Miaskowski CA (2022) Symptom clusters in patients receiving chemotherapy: a systematic review. BMJ Support Palliat Care 12(1):10\u201321. https:\/\/doi.org\/10.1136\/bmjspcare-2021-003325","journal-title":"BMJ Support Palliat Care"},{"issue":"23","key":"11000_CR16","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1056\/NEJMoa032709","volume":"350","author":"T Andre","year":"2004","unstructured":"Andre T, Boni C, Mounedji-Boudiaf L et al (2004) Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 350(23):2343\u20132351. https:\/\/doi.org\/10.1056\/NEJMoa032709","journal-title":"N Engl J Med"},{"issue":"15","key":"11000_CR17","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1200\/JCO.2006.07.9525","volume":"25","author":"MJ Moore","year":"2007","unstructured":"Moore MJ, Goldstein D, Hamm J et al (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25(15):1960\u20131966. https:\/\/doi.org\/10.1200\/JCO.2006.07.9525","journal-title":"J Clin Oncol"},{"issue":"10018","key":"11000_CR18","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","volume":"387","author":"A Wang-Gillam","year":"2016","unstructured":"Wang-Gillam A, Li CP, Bodoky G et al (2016) Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial. Lancet 387(10018):545\u2013557. https:\/\/doi.org\/10.1016\/S0140-6736(15)00986-1","journal-title":"Lancet"},{"issue":"5","key":"11000_CR19","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/annonc\/mdz060","volume":"30","author":"GM Blumenthal","year":"2019","unstructured":"Blumenthal GM, Gong Y, Kehl K et al (2019) Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer. Ann Oncol 30(5):830\u2013838. https:\/\/doi.org\/10.1093\/annonc\/mdz060","journal-title":"Ann Oncol"},{"key":"11000_CR20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1200\/CCI.20.00065","volume":"4","author":"DJ Boyne","year":"2020","unstructured":"Boyne DJ, Brenner DR, Sajobi TT et al (2020) Development of a model for predicting early discontinuation of adjuvant chemotherapy in stage III colon cancer. JCO Clin Cancer Inform 4:972\u2013984. https:\/\/doi.org\/10.1200\/CCI.20.00065","journal-title":"JCO Clin Cancer Inform"},{"key":"11000_CR21","doi-asserted-by":"publisher","DOI":"10.7249\/TL136","author":"DF McCaffrey","year":"2014","unstructured":"McCaffrey DF, Burgette LF, Griffin BA, Martin C, Ridgeway G (2014) Toolkit for weighting and analysis of nonequivalent groups: a tutorial for the TWANG SAS Macros. RAND Corporation. https:\/\/doi.org\/10.7249\/TL136","journal-title":"RAND Corporation"},{"issue":"19","key":"11000_CR22","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","volume":"32","author":"DF McCaffrey","year":"2013","unstructured":"McCaffrey DF, Griffin BA, Almirall D, Slaughter ME, Ramchand R, Burgette LF (2013) A tutorial on propensity score estimation for multiple treatments using generalized boosted models. Stat Med 32(19):3388\u20133414. https:\/\/doi.org\/10.1002\/sim.5753","journal-title":"Stat Med"},{"issue":"4","key":"11000_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1037\/1082-989X.9.4.403","volume":"9","author":"DF McCaffrey","year":"2004","unstructured":"McCaffrey DF, Ridgeway G, Morral AR (2004) Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods 9(4):403\u2013425. https:\/\/doi.org\/10.1037\/1082-989X.9.4.403","journal-title":"Psychol Methods"},{"key":"11000_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15051628","author":"S Mantziari","year":"2023","unstructured":"Mantziari S, St Amour P, Abboretti F et al (2023) A comprehensive review of prognostic factors in patients with gastric adenocarcinoma. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers15051628","journal-title":"Cancers (Basel)"},{"issue":"Suppl 1","key":"11000_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2147\/CLEP.S47150","volume":"5","author":"M Sogaard","year":"2013","unstructured":"Sogaard M, Thomsen RW, Bossen KS, Sorensen HT, Norgaard M (2013) The impact of comorbidity on cancer survival: a review. Clin Epidemiol 5(Suppl 1):3\u201329. https:\/\/doi.org\/10.2147\/CLEP.S47150","journal-title":"Clin Epidemiol"},{"issue":"1","key":"11000_CR26","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/ssu.10016","volume":"21","author":"M Gospodarowicz","year":"2003","unstructured":"Gospodarowicz M, O\u2019Sullivan B (2003) Prognostic factors in cancer. Semin Surg Oncol 21(1):13\u201318. https:\/\/doi.org\/10.1002\/ssu.10016","journal-title":"Semin Surg Oncol"},{"issue":"1","key":"11000_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1177\/1740774517741113","volume":"15","author":"MJ Palmer","year":"2018","unstructured":"Palmer MJ, Mercieca-Bebber R, King M, Calvert M, Richardson H, Brundage M (2018) A systematic review and development of a classification framework for factors associated with missing patient-reported outcome data. Clin Trials 15(1):95\u2013106. https:\/\/doi.org\/10.1177\/1740774517741113","journal-title":"Clin Trials"},{"issue":"23","key":"11000_CR28","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1056\/NEJMsb1609216","volume":"375","author":"RE Sherman","year":"2016","unstructured":"Sherman RE, Anderson SA, Dal Pan GJ et al (2016) Real-world evidence - what is it and what can it tell us? N Engl J Med 375(23):2293\u20132297. https:\/\/doi.org\/10.1056\/NEJMsb1609216","journal-title":"N Engl J Med"},{"key":"11000_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102915","volume":"78","author":"BE Wilson","year":"2024","unstructured":"Wilson BE, Booth CM (2024) Real-world data: bridging the gap between clinical trials and practice. EClinicalMedicine 78:102915. https:\/\/doi.org\/10.1016\/j.eclinm.2024.102915","journal-title":"EClinicalMedicine"},{"issue":"3","key":"11000_CR30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/bmjqs-2020-012206","volume":"31","author":"D Mou","year":"2022","unstructured":"Mou D, Horn DM, Heng M et al (2022) Primary care physician\u2019s (PCP) perceived value of patient-reported outcomes (PROs) in clinical practice: a mixed methods study. BMJ Qual Saf 31(3):221\u2013229. https:\/\/doi.org\/10.1136\/bmjqs-2020-012206","journal-title":"BMJ Qual Saf"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-11000-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-11000-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T14:55:29Z","timestamp":1786200929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-11000-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["11000"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-11000-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Dana-Farber\/Harvard Cancer Center (DF\/HCC) Institutional Review Board (IRB protocol number: 25\u2013048).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves secondary data analysis and does not require patient consent.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involves secondary data analysis and does not require consent to publish.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"763"}}